Virus like particles as a novel platform for delivery of protective antigens of burkholderia r & d effort.

Ended Awarded Last action

Contract number
0002
Awardee
Awarding agency
Obligated
$3,181,245

Award facts

Contract value 81% obligated
  • $3,271,125.00 Current, with exercised options
  • $3,947,011.00 Potential, with all options
Completion date 100% complete
  • Current, with exercised options
  • Potential, with all options
Set-aside
No set-aside
Competition
Not Competed Only One Source
Pricing
Cost Plus Fixed Fee
Place of performance
Great Britain, United Kingdom

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action 12 · Research and development services for virus like particles VLP as a novel platform for delivery of protective antigens of burkholderia. -$30,131
Other Administrative Action A00001 -$59,749
Supplemental Agreement for work within scope 11 $0
Supplemental Agreement for work within scope 10 · Option period 2 $402,290
Supplemental Agreement for work within scope 9 $0
Supplemental Agreement for work within scope 8 $0
Supplemental Agreement for work within scope 7 $0
Other Administrative Action 6 $0
Exercise an Option 5 $1,021,180
Other Administrative Action 4 $0
Funding Only Action 3 $250,000
Other Administrative Action 2 · Option period 1 $0
Exercise an Option 1 · Base period $853,557
Original award $744,098
Show all 14

About this award

This is a $3,947,011.00 cost-plus-fixed-fee delivery order contract awarded by the Defense Threat Reduction Agency (DTRA) to the Ministry of Defence (MOD) of the United Kingdom, operating as the Defence Science and Technology Laboratory (DSTL). The contract is for a research and development effort focused on using virus-like particles as a novel platform for delivering protective antigens against Burkholderia bacteria.

The contract does not have a set-aside designation. DSTL is a well-established research partner for U.S. federal agencies, having secured a $146.3 million Indefinite Delivery Contract with the National Institute of Allergy and Infectious Diseases for providing pre-clinical research models to evaluate countermeasures against various infectious agents, including those with pandemic potential. This specific award to DSTL demonstrates DTRA's continued collaboration with international partners to advance medical countermeasure development for biological threats.

Quick answers

Who was awarded contract 0002?

0002 was awarded to Ministry Of Defence by Defense Threat Reduction Agency (Department of Defense) on July 1, 2012.

How much is contract 0002 worth?

The government has obligated $3,181,245 on 0002. Its current value, with exercised options, is $3,271,125. Its potential value, with all options, is $3,947,011.

Is contract 0002 an order under another contract?

Yes. 0002 is a delivery order under HDTRA112D0003, an indefinite delivery contract.

Was contract 0002 competed?

The extent of competition for 0002 was not competed.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award